This article is provided for educational and informational purposes only. All compounds discussed are supplied strictly for laboratory and research use. Vitro Labs products are analytical-grade biochemical reference standards and are not for human or animal consumption, therapeutic use, clinical use, diagnostic use, or administration of any kind.
A four-constituent compound blend is a harder analytical problem than a single compound, and the Certificate of Analysis has to prove it. KLOW Blend is Vitro Labs’ proprietary reference standard combining four well-studied research-grade compounds in a single lyophilized vial: BPC-157 (10 mg), TB-500 (10 mg), GHK-Cu (50 mg), and KPV (10 mg). For qualified research customers running identity verification, analytical method development, or comparative in-vitro work, the value of a blend reference standard depends entirely on the documentation that ships with it.
This article walks through what a four-constituent COA has to demonstrate, why HPLC purity is reported per constituent rather than as a single blend value, how net compound content is calculated when four compounds share a vial, and what documentation Freedom Diagnostics. the ISO-accredited independent analytical laboratory Vitro uses. provides on a lot-specific basis. Every claim is framed at the analytical-chemistry level. Nothing here is a protocol, a dose, or a recommendation for use in humans or animals. This is a sourcing and documentation reference for laboratory research use only.
KLOW Blend is an analytical-grade biochemical reference standard supplied by Vitro Labs as a single lyophilized vial containing four compounds at labeled masses. The name is a mnemonic for the four constituents. but the product itself is a co-lyophilized preparation, meaning the four compounds are dissolved together, filtered, and freeze-dried as one solid cake.
Researchers evaluating co-formulated compound chemistry, method-development workflows for multi-analyte HPLC, or comparative identity studies use this format as a single-sourced reference material with a single lot number and a single certificate.
What KLOW Blend is not: a clinical product, a therapy, a supplement, a drug, or anything intended for administration to humans or animals. It is a laboratory research material sold to qualified research customers for in-vitro research, analytical method development, identity verification, and laboratory evaluation. The distinction matters because the documentation standard for a research reference material is different from a pharmaceutical spec sheet.
A COA on a research-grade compound reports what an independent analytical laboratory measured for that specific lot. It does not represent safety, efficacy, sterility, or fitness for any use outside a controlled research setting.
Researchers studying tissue-repair signaling frequently want to characterize the analytical behavior of BPC-157, TB-500, GHK-Cu, and KPV in the same solvent system and on the same instrument run. A co-lyophilized blend removes several sources of variability: the same water content, the same freeze-drying cycle, the same fill weight tolerance. When the goal is a method-development experiment comparing chromatographic behavior across a related compound family, having one vial with four compounds is a cleaner starting point than four separate vials.
A single-compound COA answers one identity question and one purity question. A four-constituent blend COA has to answer four of each. The chromatographic method has to resolve four peaks well enough to integrate them individually. The mass spectrometry method has to identify four molecular ions, each at a different mass. And the net content has to add up to the labeled total across four independent measurements.
The analytical bar is real. If a method cannot separate two of the four compounds. say, if BPC-157 and KPV co-elute at a given gradient. then the reported purity for each is ambiguous. A competent independent laboratory develops a method that separates all four with baseline resolution, verifies the retention times against pure reference standards for each constituent, and reports the results with the method documented on the certificate.
Before walking through the COA, a brief structural note on each of the four compounds. enough to make the identity and purity sections meaningful.
BPC-157 is a synthetic 15-amino-acid compound derived from a partial sequence of a protein found in human gastric juice. Sikirić and colleagues at the University of Zagreb characterized the compound across a long preclinical literature dating to the 1990s, with mechanistic work continuing into the 2010s (Sikiric et al., 2013, PMID: 22950504). At the structural level, it is a linear compound with a monoisotopic mass in the range that LC-MS instruments resolve cleanly from the other three KLOW constituents.
TB-500 is the common research name for a 17-amino-acid fragment corresponding to the active region of thymosin beta-4, a naturally occurring actin-binding protein. Preclinical studies have characterized the fragment’s behavior in models of tissue repair signaling and cellular migration (Goldstein et al., 2005, PMID: 16374022). It is a larger compound than KPV or BPC-157, giving it a distinct retention time on a reversed-phase HPLC column and a distinct mass signature on LC-MS.
GHK-Cu is a copper complex composed of the 3-amino-acid compound glycyl-L-histidyl-L-lysine bound to a copper(II) ion. Pickart’s laboratory first isolated the 3-amino-acid compound in the 1970s and characterized its copper-binding chemistry across subsequent decades (Pickart and Margolina, 2018, PMID: 30011351). The copper coordination is central to the compound’s identity. the COA has to confirm not just the amino-acid backbone but the presence of the metal complex, which affects the UV spectrum and can be confirmed by copper-specific analytical methods.
KPV is a 3-amino-acid compound consisting of lysine, proline, and valine. It corresponds to the C-terminal fragment of alpha-melanocyte-stimulating hormone (α-MSH) and has been studied in preclinical models of inflammatory signaling (Cutuli et al., 2000, PMID: 10708577). At three amino acids, it is the smallest constituent in the blend, with a low monoisotopic mass and a short retention time on reversed-phase HPLC. usually eluting well before the longer compounds.
Identity confirmation on a compound reference standard is done by liquid chromatography–mass spectrometry (LC-MS). The compound is dissolved, injected onto a column, separated into peaks, and each peak is ionized and measured for its monoisotopic mass. If the measured mass matches the theoretical mass calculated from the compound’s amino-acid sequence. usually within a few parts per million. identity is confirmed.
For a four-constituent blend, the identity section of the COA lists each compound with its expected mass and its observed mass. On a Freedom Diagnostics report, this appears as a table: constituent name, theoretical [M+H]⁺, observed [M+H]⁺, and a pass/fail on the match. All four have to match for the lot to pass identity.
Alternative identity methods. amino-acid analysis, N-terminal sequencing, NMR. are all valid but slower and more expensive. LC-MS gives a fast, reproducible answer that is directly interpretable against the sequence. For a research reference material intended to serve as an analytical standard, the LC-MS mass is what other laboratories will use to verify their own samples against, so reporting it explicitly on the COA is the most useful documentation the certificate can carry.
Purity is measured by HPLC-UV: the sample is separated on a reversed-phase column, a UV detector measures the absorbance at a compound-appropriate wavelength (usually 214 nm for the amide bond or 280 nm when aromatic residues are present), and the resulting chromatogram is integrated. The area under each peak is reported as a percentage of the total integrated area.
For KLOW Blend, the chromatogram contains four main peaks. one for each constituent. plus any minor peaks representing synthesis-related impurities, oxidation products, or truncated sequences. A well-developed method separates the four main peaks with baseline resolution, meaning the signal returns to zero between them, so each can be integrated independently.
On a KLOW COA, HPLC purity can be reported in two ways depending on the laboratory’s convention:
| Reporting convention | What the number means | Typical use |
|---|---|---|
| Per-constituent area purity | Purity of that named compound relative to the impurities eluting near it (constituent peak / (constituent peak + its associated impurities)). | Preferred for reference standards. each compound gets its own purity number. |
| Total blend area distribution | Fraction of the total chromatogram attributable to each named compound vs. all peaks combined. | Useful for confirming the mass ratio matches the label but less informative about the purity of each individual constituent. |
Freedom Diagnostics’ KLOW COA reports per-constituent area purity, which is the more analytically meaningful of the two. it answers the question “how clean is this particular compound?” rather than “how much of the vial is this compound?”
A lyophilized compound vial is not pure compound. It contains residual water (from the freeze-drying process), counter-ions (usually trifluoroacetate or acetate from purification), and any excipients used in the formulation. The net compound content. the actual mass of amino-acid backbone material. is what a researcher needs to know for accurate stoichiometric calculations.
For KLOW Blend, the net content section on the COA reports the measured mass of each of the four compounds in the vial, adjusted for water and salt content. The label says BPC-157 10 mg / TB-500 10 mg / GHK-Cu 50 mg / KPV 10 mg. total 80 mg. The COA reports what the analytical laboratory actually measured for that lot.
Net content is calculated from three inputs: the fill weight of the vial (measured on a calibrated balance during production), the HPLC purity percentage (from the chromatogram integration described above), and a moisture and counter-ion correction (typically determined by Karl Fischer titration and ion chromatography, or estimated from the synthesis conditions when direct measurement is not run per lot). The result is a mass value in milligrams for each constituent, reported alongside the label claim.
A reference-standard COA typically reports observed net content within a defined tolerance of the label claim. often ±5% for research materials. A lot that measured, for example, 9.7 mg of BPC-157 against a 10.0 mg label is within tolerance and passes. A lot that measured 8.2 mg would not, and the material would not be released with that lot identifier.
Two smaller but important sections on the COA: appearance and method.
Appearance describes what the material physically looks like as issued from the fill line. For a co-lyophilized four-compound blend, the typical description is a white to off-white lyophilized cake or powder. The GHK-Cu component can impart a very faint blue tint from the copper coordination, though this is usually not visible in the small mass of copper present in a 50 mg fill of the 3-amino-acid compound complex. Any deviation from the expected appearance is a lot-level flag.
Method documents the analytical procedures used to generate the numbers on the certificate: the HPLC column type, gradient, flow rate, and detector wavelength; the mass spectrometer ionization mode and mass range; the moisture determination method if applied. Method disclosure lets another laboratory reproduce the analysis if they need to verify the material against their own reference standard.
“A Certificate of Analysis without a method section is a claim without evidence. Reproducibility requires knowing how the numbers were generated.”
, Editorial framing consistent with ISO/IEC 17025 documentation standards for analytical testing laboratories.
Vitro Labs uses Freedom Diagnostics, an independent analytical laboratory based in Franklin, Tennessee, for lot-specific Certificate of Analysis testing on every batch. Freedom Diagnostics operates as a third-party contract analytical laboratory. meaning it is not owned by, affiliated with, or financially entangled with compound vendors. It bills for testing services and reports the results as measured.
Independent third-party testing matters because it separates the analytical claim from the commercial interest. A vendor-generated COA reports what the vendor wants the acquirer to see. An independent COA reports what a laboratory with no stake in the listing actually measured. For a qualified research customer building an analytical workflow, the difference is the difference between a marketing document and a data source.
⚗️ Research Disclaimer: All content on this page is intended exclusively for licensed researchers, academic institutions, and scientific professionals operating within approved laboratory settings. KLOW Blend and its constituent compounds are research compounds not approved for human clinical use by the FDA or equivalent regulatory authorities. This content does not constitute medical advice, clinical guidance, or a recommendation for use in humans or animals outside of approved research protocols. KLOW Blend is supplied strictly for laboratory research use only.
A KLOW Blend Certificate of Analysis from Freedom Diagnostics is typically a single-page document organized into five sections. Reading it well is a matter of knowing what each section is supposed to prove.
What is not on the certificate matters too. Read the next section for what a KLOW COA does not represent.
Analytical honesty about what a certificate covers is as important as the analyses themselves. The KLOW Blend COA reports identity, HPLC purity, net content, appearance, and method. It does not report:
The four omitted categories. sterility, endotoxin, heavy metals, biological activity. are analyses that some pharmaceutical-grade materials carry and that research-grade reference standards typically do not. If a research protocol requires any of them, that requirement has to be met with additional testing arranged by the end-user laboratory or by sourcing pharmaceutical-grade material through the appropriate regulatory channels. KLOW Blend is not that material and is not represented as that material.
⚠️ Research Disclaimer: This article is for educational and informational purposes only. All compounds discussed are research chemicals for laboratory use only and are not for human consumption. Unless expressly stated in writing by Vitro Labs, products are not represented as sterile, pyrogen-free, endotoxin-free, or suitable for administration of any kind.
The COA describes the material as issued. Once a vial is in laboratory inventory, handling determines whether the analytical claims on the certificate still apply.
Lyophilized compounds are broadly stable at freezer temperatures (typically −20 °C, colder for long-term storage) in their sealed vials. The four KLOW constituents have different individual stability profiles. BPC-157 and TB-500 are relatively robust as lyophilized solids; GHK-Cu’s copper coordination introduces some sensitivity to reducing conditions; KPV as a 3-amino-acid compound is chemically simple and stable. As a co-lyophilized preparation, the blend’s overall stability is broadly consistent with the more sensitive constituent, and manufacturer storage recommendations reflect that.
Once reconstituted, all four compounds become more susceptible to degradation pathways: hydrolysis of the amide bonds, oxidation of susceptible residues, and (for GHK-Cu specifically) disruption of the copper complex if the pH or redox state of the diluent shifts. Analytical laboratories working with reconstituted compound reference standards typically re-verify identity and purity on any sample that has been in solution for more than a few days.
None of this constitutes a protocol or a recommendation for a specific handling procedure. Individual laboratory SOPs, storage equipment, and research applications vary. The manufacturer’s storage guidance and the researcher’s institutional protocols govern actual handling.
KLOW Blend is supplied as an analytical-grade biochemical reference standard for laboratory research use only. It is not a drug, not a supplement, not a compounded pharmacy product, and not an outsourcing-facility product. Vitro Labs is a chemical supplier, not a 503A compounding pharmacy or a 503B outsourcing facility.
The material is sold to qualified research customers under terms that require confirmation of research use and prohibit use for human or animal consumption, therapeutic use, clinical use, diagnostic use, dietary supplementation, dosing, injection, ingestion, or administration.
For researchers evaluating sourcing options, three documents provide the operational picture:
Researchers investigating the individual constituents of KLOW Blend may also review the reference materials for each compound separately: the BPC-157 + TB-500 combined reference, the GHK-Cu copper complex reference, and forthcoming individual references on KPV and the complete GLOW/KLOW blend family. The full Vitro Labs Research Library hosts the mechanism, comparison, and sourcing articles for each constituent and for the blend as a whole.
Independent third-party testing for compound reference materials is not universal in the research-chemical supply category. Many suppliers issue vendor-generated COAs or reproduce a manufacturer’s certificate without independent verification. The value of a Freedom Diagnostics COA on a Vitro Labs lot is precisely that the analytical work was performed by a laboratory with no commercial stake in the listing, and the numbers on the certificate reflect what that laboratory measured. For a qualified research customer building analytical workflows around a reference material, that separation of interests is the point of the documentation.
A KLOW Blend COA from Freedom Diagnostics documents five things: (1) identity of each of the four constituents (BPC-157, TB-500, GHK-Cu, KPV) confirmed by LC-MS mass matching; (2) HPLC-UV area purity reported per constituent; (3) net compound content per constituent against the label claim; (4) physical appearance of the lyophilized material; and (5) the analytical methods used. The certificate is lot-specific and reflects measurements on that particular batch. It does not report sterility, endotoxin, heavy-metal, or bioactivity testing, which are not performed on this research-grade reference material.
Because a blend contains multiple distinct compounds, each with its own chromatographic peak and its own set of synthesis-related impurities. Reporting a single purity number for the whole vial would obscure whether one constituent is clean and another is not. Per-constituent area purity. the peak area of each named compound relative to the impurities eluting near it. is the analytically meaningful measurement. A well-developed HPLC method separates the four KLOW peaks with baseline resolution so each can be integrated independently.
Freedom Diagnostics is an independent analytical laboratory based in Franklin, Tennessee, that provides third-party contract testing services for compound reference materials. Vitro Labs uses Freedom Diagnostics for lot-specific COA testing on every batch. Independent testing matters because the laboratory has no commercial stake in the listing of the material. it reports what it measures, not what the vendor wants to see. This separation of interests is the analytical basis for treating the COA as a data source rather than a marketing document.
KLOW Blend is labeled at 80 mg total compound content per vial, distributed across four constituents: BPC-157 10 mg, TB-500 10 mg, GHK-Cu 50 mg, and KPV 10 mg. The net content section of the COA reports the actual measured mass of each constituent for the specific lot, adjusted for moisture and counter-ion content, versus the label claim. Reference-standard tolerance windows are typically ±5% of the label claim for research materials.
No. The KLOW Blend COA reports identity (LC-MS), HPLC purity, net content, appearance, and method. It does not report sterility, endotoxin, or heavy-metal testing. Those analyses are not performed on this material and are not represented on the certificate. KLOW Blend is a research-grade analytical reference standard supplied for laboratory research use only and is not represented as sterile, pyrogen-free, or endotoxin-free. Research applications that require those characterizations would need to arrange the appropriate additional testing at the end-user laboratory.
The four compounds span a wide mass range. KPV at ~342 Da (3-amino-acid compound), GHK-Cu at ~403 Da (3-amino-acid compound plus copper), BPC-157 at ~1419 Da (15 amino acids), and TB-500 at ~1888 Da (17 amino acids). On LC-MS, each has a distinct molecular ion, making identity confirmation straightforward. On reversed-phase HPLC, the smaller and more polar compounds (KPV and GHK-Cu) generally elute earlier than the longer, more hydrophobic compounds (BPC-157 and TB-500). A properly developed gradient separates all four with baseline resolution, allowing per-constituent integration on the certificate.
⚗️ Research Disclaimer: All content on this page is intended exclusively for licensed researchers, academic institutions, and scientific professionals operating within approved laboratory settings. KLOW Blend and its constituent compounds are research compounds not approved for human clinical use by the FDA or equivalent regulatory authorities. This content does not constitute medical advice, clinical guidance, or a recommendation for use in humans or animals outside of approved research protocols. KLOW Blend is supplied strictly for laboratory research use only.
